BUSINESS Biotechnology
  NEWS
  Politics
  Nation
  World
  Metro
  Style
    BUSINESS
    Market News
    Portfolio
    Company Research
    Economy
    Policy
    Metro Business
    Industries
     Biotechnology
   - Defense/ Aerospace
   - Energy
   - Financial Services
   - Food
   - Hospitality
   - Insurance
   - Internet
   - Law Firms
   - Media
   - Pharmaceuticals
   - Retail
   - Telecom
   - Transportation
    Personal Finance
    Mutual Funds
    Special Reports
    Columnists
    Live Discussions
    Business Index
  Technology
  Health
  Education
  Real Estate
  Obituaries
  Corrections
  Archives

washingtonpost.com > Business > Industries > Biotechnology
Quick Quotes

Look Up Tables | Portfolio | Index


Biotechnology Stocks to Watch
Abgenix | Amgen | Biogen | BioReliance | Celera Genomics | Digene | EntreMed | Gene Logic | Genentech | Genome Therapeutics | Guilford | Human Genome Sciences | IGEN Int'l | Martek | MedImmune | Meridian Medical North American Vaccine | Novavax | Vertex

Post 200: Top Biotech Companies

Other IndustryWatch Pages
Washtech
 Biotech/Medical
 More From Washtech.com
Human Genome Project
In June, two teams of scientists announced they had completed the world's first working drafts of the entire human genetic code. The accomplishment launches a new era in medicine.

The long-term ramifications are profound. In many ways, society is unprepared for the full implications.

The Washington Post and washingtonpost.com explore these issues in depth with a package of stories and special reports.

Background
The Human Genome Project formally began in October 1990 with the goals of identifying the more than 100,000 genes in human DNA, determining the sequences of the 3 billion chemical base pairs in DNA, and storing this information in databases for future analysis and application.

The National Institutes of Health's Human Genome Research Institute and the Department of Energy's Human Genome Program together make up the U.S. Human Genome Project. The U.K.'s Wellcome Trust, a private philanthropy, also contributes to the global initiative.

Q & A on the Human Genome

Top Gene-Related Patent Holders
Company/Organization Patents
U.S. Government 388
Incyte Pharmaceuticals 356
University of California 265
SmithKline Beecham 197
Genentech 175
Eli Lilly 145
Novo Nordisk 142
IBM 130
Chiron 129
American Home Products 117
 
(Source: PricewaterhouseCoopers)
In the News
Tex. Pressed on DNA Exonerations: Group Is Urged to Probe Cause of Erroneous Murder Convictions (Post, April 20, 2005)

CONTRACTS AWARDED (Post, April 18, 2005)

Biotech Company Bets on Cattle's Future: Beltsville's MetaMorphix Hopes DNA Testing for Tenderness and Taste Will Catch On (Post, April 18, 2005)

Pediatric Vaccine Stockpile at Risk: Makers Hesitate to Supply Government (Post, April 17, 2005)

Pressure Is Building on NIH to Reconsider Conflict Rules (Post, April 17, 2005)

FDA Orders Levitra Ad Off the Air: TV Spot Doesn't Explain Drug's Side Effects (Post, April 16, 2005)

Duncan's Faith May Not Follow Church (Post, April 14, 2005)

FDA Panel Opposes Silicone Gel Implants (Post, April 13, 2005)

Cloned Cows' Milk, Beef Up to Standard: Researchers Find No Significant Differences With Products of Conventionally Raised Cattle (Post, April 12, 2005)

Democrats Approve Agenda in Final Push: Maryland Bills Include Gay Rights, Labor Issues; Slots Effort Fails Again (Post, April 12, 2005)

Painkiller Decision Suggests Shift In FDA's Risk-Benefit Equation (Post, April 11, 2005)

50 Years After Vaccine, Polio's Legacy Endures: Era Marked by Panic, Then Relief, Shaped Lives and Medical Research (Post, April 10, 2005)

NIH Agency Chiefs Criticize Federal Policy on Stem Cells (Post, April 7, 2005)

Labs Turn DNA Into Personal Health Forecasts (Post, April 7, 2005)

HGS Arthritis Drug Clears Testing Hurdle: Treatment Reduced Symptoms in Study (Post, April 6, 2005)

Technique to Fix DNA Flaws Is Tested (Post, April 4, 2005)

New Ethics Rules Cost NIH Another Top Researcher (Post, April 2, 2005)

GOP, Democrats Look for Symbolism in Schiavo Case (Post, April 1, 2005)

Tougher Rules Urged for Auto Roofs (Post, March 31, 2005)

Mass. Senate Passes Stem Cell Bill That May Face Governor's Veto (Post, March 31, 2005)

More Stories

Feature Story
20 Years Later, Stolen Gene Haunts a Biotech Pioneer
The men with foreign accents trod carefully through desolate hallways. They weren't supposed to be there, but the University of California at San Francisco had something they wanted, and they knew just where to find it.

Pharmaceuticals
Contraceptive Sponge to Return to Market (AP, April 23, 2005; 1:30 AM)

Probe of FDA Breast Implant Review Sought (AP, April 23, 2005)

Sponge Contraceptive Returning to Market (Reuters, April 22, 2005; 8:03 PM)

More Stories


© 2002-2005 The Washington Post Company